0001127602-23-028095.txt : 20231120
0001127602-23-028095.hdr.sgml : 20231120
20231120211446
ACCESSION NUMBER: 0001127602-23-028095
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231116
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farrell Michael J.
CENTRAL INDEX KEY: 0001485164
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15317
FILM NUMBER: 231424305
MAIL ADDRESS:
STREET 1: C/O REMED INC
STREET 2: 9001 SPECTRUM CTR. BLVD.
CITY: SAN DIEGO,
STATE: CA
ZIP: 92123
FORMER NAME:
FORMER CONFORMED NAME: Farrell Michael
DATE OF NAME CHANGE: 20100224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RESMED INC
CENTRAL INDEX KEY: 0000943819
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 980152841
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
BUSINESS PHONE: 8587462400
MAIL ADDRESS:
STREET 1: 9001 SPECTRUM CENTER BLVD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92123
4/A
1
form4a.xml
PRIMARY DOCUMENT
X0508
4/A
2023-11-16
2023-11-20
0000943819
RESMED INC
RMD
0001485164
Farrell Michael J.
RESMED INC.
9001 SPECTRUM CENTER BLVD
SAN DIEGO
CA
92123
1
Chief Executive Officer
0
ResMed Common Stock
4090
I
Lisette and Michael Farrell Family Trust
ResMed Common Stock
2023-11-16
4
M
0
3462
57.76
A
444448
D
ResMed Common Stock
2023-11-16
4
F
0
1343
148.90
D
443105
D
ResMed Common Stock
2023-11-20
4
F
0
2352.929
148.94
D
440752
D
ResMed Common Stock Options
57.76
2023-11-16
4
M
0
3462
0
D
2017-11-11
2023-11-16
ResMed Common Stock
3462
0
D
ResMed Common Stock Options
148.90
2023-11-16
4
A
0
55468
148.90
A
2024-11-11
2030-11-16
ResMed Common Stock
55468
55468
D
Original form amended to include a plan provision auto-exercise prior to option grant expiration.
Disposition to issuer for exercise cost of options auto-exercised under the plan.
Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020.
Transaction was a plan auto exercise prior to expiration.
Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2024, 2025, and 2026.
Michael J. Farrell, Chief Executive Officer
2023-11-20